One surprising finding in this study is that GPI-scFv X5 not only effectively blocks HIV-1 cell-cell infection of CD4+ cell lines or human primary CD4+ T cells in trans from either iDC or mDC-captured HIV-1, but it also blocks HIV-1 infection of the iDCs (Figures 3, 5). This evidence concerns the gene CD4 and HIV-1 infection.